Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Upgrade to StreetInsider Premium - FREE TRIAL!
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Analyst Comments
Hot Analyst Comments $
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades $
New Coverage News
Hot New Coverage $
Upgrade News
Hot Upgrades $
More...
M&A Insider
Merger News
Hot M&A News $
Private Equity
Rumors $
Merger Arbitrage
2012's Top M&A Deals
Top 50 Takeover Targets
More...
EPS Insider
Earnings Calendar
Earnings News
Hot Earnings $
Guidance
Hot Guidance $
Conference Calls
Earnings History Search
More...
Dividend Insider
Dividend News
Special Dividends $
Stock Buybacks
Hot Stock Buybacks $
Stock Splits
More...
IPO Insider
IPO News
Recent IPOs
Upcoming IPOs
More...
Hedge Fund Insider
Hedge Funds News
More...
Partners
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
*NEW SI App
Newsletters
Follow @Street_Insider
More on DRTX
- Summary
- Chart
- Profile
- Historical
Data
- Earnings
- Ratings
News
- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...
- 13Ds
- 13Fs
- 13Gs
- Analyst Comments
- Analyst EPS Change
- Analyst EPS View
- Analyst PT Change
- Commodities
- Conference Calls
- Contributors
- Corporate News
- Credit Ratings
- Dividends
- Downgrades
- Earnings
- Economic Data
- Equity Offerings
- ETFs
- FDA
- Fed
- Forex
- General News
- Hedge Funds
- Hot Buybacks
- Hot Comments
- Hot Corp. News
- Hot Dividends
- Hot Downgrades
- Hot Earnings
- Hot FDA News
- Hot Guidance
- Hot Hedge Fund News
- Hot Insider Trades
- Hot IPOs
- Hot List
- Hot M&A
- Hot Mgmt Changes
- Hot New Coverage
- Hot Upgrades
- Insiders' Blog
- IPOs
- Life Enjoyed
- Litigation
- Management Comments
- Market Check
- Momentum Movers
- New Coverage
- Option EPS Action
- Options
- Press Releases
- Private Equity
- SEC Filings
- Special Dividends
- Special Reports
- Stock Splits
- Technicals
- Trader Talk
- Trading Halts
- Upgrades
DURATA THERAP (NQ:DRTX)
Delayed:
6.94
-0.17 (2.39%)
Trade Now!
Previous Close
$7.11
52 Week High
$10.63
Open
$7.14
52 Week Low
$6.65
Day High
$7.17
P/E
N/A
Day Low
$6.90
EPS
$-260.23
Volume
28,202
Friends, Peers and Foes
(?)
:
HPTX
,
KBIO
,
CBST
CRTX
(more...)
ALERTS
|
RSS
All Recent
SI Reports
Press Releases
SEC Filings
Major News
May 20, 2013 09:51 PM
Form 4 Durata Therapeutics, For: May 16 Filed by: OBOYLE KEVIN C
May 20, 2013 09:47 PM
Form 4 Durata Therapeutics, For: May 16 Filed by: FRIEDMAN PAUL A
May 20, 2013 09:45 PM
Form 4 Durata Therapeutics, For: May 16 Filed by: Giles Lisa M.
May 20, 2013 09:39 PM
Form 4 Durata Therapeutics, For: May 16 Filed by: DE SCHUTTER RICHARD U
May 20, 2013 01:37 PM
Form 4 Durata Therapeutics, For: May 20 Filed by: Edick Paul R
May 17, 2013 02:20 PM
Form 8-K Durata Therapeutics, For: May 16
May 16, 2013 01:44 PM
Paul A. Friedman, M.D. is Elected to Durata Therapeutics' Board of Directors
May 9, 2013 08:07 AM
Form 10-Q Durata Therapeutics, For: Mar 31
May 9, 2013 08:01 AM
Form 8-K Durata Therapeutics, For: May 09
May 9, 2013 07:31 AM
Durata Therap (DRTX) Posts Q1 Loss of 86c/Share
View All Articles
May 9, 2013 07:31 AM
Durata Therap (DRTX) Posts Q1 Loss of 86c/Share
Nov 9, 2012 07:47 AM
Durata Therap (DRTX) Posts Wider than Expected Q3 Loss of $1.47/Share
Sep 4, 2012 07:46 AM
Durata Therap (DRTX) Narrows Q2 Loss to $183.31/Share
Jul 19, 2012 11:05 AM
Durata Therapeutics (DRTX) IPO Opens Slightly Higher
Jul 19, 2012 09:47 AM
Durata Therapeutics (DRTX) IPO Prices at $9, Below Expected Range
May 9, 2013 07:31 AM
Durata Therap (DRTX) Posts Q1 Loss of 86c/Share
Apr 29, 2013 07:38 AM
Durata (DRTX) Issues Encouraging Update on Dalbavancin Phase I
Apr 12, 2013 07:31 AM
Durata Therapeutics (DRTX) Prices 7.15M Shares at $7
Apr 10, 2013 09:34 AM
StreetInsider.com Pre-Open Movers 4/10: (WOR) (YHOO) (FB) Higher; (TITN) (HMA) (FSLR) Lower (more...)
Apr 9, 2013 06:11 PM
Streetinsider.com After-Hours Movers 4/09: (WOR) (PSMT) Higher; (HMA) (RLGY) (THC) Lower (more...)
Mar 15, 2013 07:47 AM
Credit Suisse Assumes Durata Therapeutics (DRTX) at Outperform
Jan 4, 2013 08:31 AM
Durata Therapeutics (DRTX) Reports DISCOVER 1 Phase 3 Met Primary, Secondary Endpoint
Dec 11, 2012 08:21 AM
Durata (DRTX) Phase 3 Results for Dalbavancin in the Treatment of ABSSSI
Nov 14, 2012 10:09 AM
Durata Therapeutics (DRTX) Moving Corp. HQ to Windy City
Nov 9, 2012 07:47 AM
Durata Therap (DRTX) Posts Wider than Expected Q3 Loss of $1.47/Share
View All Reports
May 16, 2013 01:44 PM
Paul A. Friedman, M.D. is Elected to Durata Therapeutics' Board of Directors
May 9, 2013 07:00 AM
Durata Therapeutics, Inc. Reports First Quarter 2013 Financial Results
May 7, 2013 07:30 AM
Durata Therapeutics to Present at Bank of America Merrill Lynch 2013 Healthcare Conference
May 2, 2013 07:30 AM
Durata Therapeutics to Announce First Quarter 2013 Financial Results on May 9, 2013
May 2, 2013 06:00 AM
Sofinnova Ventures Announces Team Expansion and Promotion
Apr 29, 2013 07:30 AM
Phase I Data Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Weekly Doses of Dalbavancin Presented at the 23rd Annual ECCMID Meeting
Apr 29, 2013 07:30 AM
New Data Demonstrating In Vitro Potency of Dalbavancin Against Bacterial Pathogens Presented at the 23rd Annual ECCMID Meeting
Apr 24, 2013 07:30 AM
Durata Therapeutics to Present Two Dalbavancin Posters at the 23rd Annual ECCMID Meeting
Apr 22, 2013 03:30 PM
Durata Therapeutics to Present at the 2013 Needham Healthcare Conference
Apr 17, 2013 04:15 PM
Durata Therapeutics Closes Public Offering of Common Stock
View All Press Releases
May 20, 2013 09:51 PM
Form 4 Durata Therapeutics, For: May 16 Filed by: OBOYLE KEVIN C
May 20, 2013 09:47 PM
Form 4 Durata Therapeutics, For: May 16 Filed by: FRIEDMAN PAUL A
May 20, 2013 09:45 PM
Form 4 Durata Therapeutics, For: May 16 Filed by: Giles Lisa M.
May 20, 2013 09:39 PM
Form 4 Durata Therapeutics, For: May 16 Filed by: DE SCHUTTER RICHARD U
May 20, 2013 01:37 PM
Form 4 Durata Therapeutics, For: May 20 Filed by: Edick Paul R
May 17, 2013 02:20 PM
Form 8-K Durata Therapeutics, For: May 16
May 9, 2013 08:07 AM
Form 10-Q Durata Therapeutics, For: Mar 31
May 9, 2013 08:01 AM
Form 8-K Durata Therapeutics, For: May 09
Apr 19, 2013 04:14 PM
Form SC 13G Durata Therapeutics, Filed by: Vivo Ventures VI, LLC
View All Filings
Entities mentioned with
DRTX
Bank of America
|
View Related Stories »
Earnings
|
View Related Stories »
Credit Suisse
|
View Related Stories »
Merrill Lynch
|
View Related Stories »
RBC Capital
|
View Related Stories »
Jefferies & Co
|
View Related Stories »
JMP Securities
|
View Related Stories »
Community Health/Tenet Healthcare
|
View Related Stories »
Stifel Nicolaus
|
View Related Stories »
UBS
|
View Related Stories »
Morgan Stanley
|
View Related Stories »
Barclays
|
View Related Stories »
Notable Analyst Rating Changes
|
View Related Stories »
Wells Fargo
|
View Related Stories »
Canaccord Genuity
|
View Related Stories »
Barack Obama
|
View Related Stories »
After-Hours Movers
|
View Related Stories »
13G
|
View Related Stories »
Needham & Company
|
View Related Stories »
JPMorgan
|
View Related Stories »
Show More...
View All Entities